Thomas Szekeres

Medical University of Vienna — Austria

Medicine · Health Sciences

43h-index7.9kcitations296works9.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sirtuins and Resveratrol in Medicine(39), Metal complexes synthesis and properties(30), Biochemical and Molecular Research(30), Metal-Catalyzed Oxygenation Mechanisms(29), HIV/AIDS drug development and treatment(18)

Publications279 total

Virucidal Potential of 3,3′,4,4′,5,5′-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus
Viruses·2025Open Access
TOP-190 Biomarkers of pathophysiological mechanisms identify stage- specific divers of disease progression in ACLD
Journal of Hepatology·2025
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases
Neuro-Oncology·2024· 49 citedOpen Access
Abstract PO2-04-05: FINAL OUTCOME ANALYSIS FROM THE PHASE II TUXEDO-1 TRIAL OF TRASTUZUMAB-DERUXTECAN IN HER2-POSITIVE BREAST CANCER PATIENTS WITH ACTIVE BRAIN METASTASES
Cancer Research·2024· 2 cited
Hemolysis Index Correlations with Plasma-Free Hemoglobin and Plasma Lactate Dehydrogenase in Critically Ill Patients under Extracorporeal Membrane Oxygenation or Mechanical Circulatory Support—A Single-Center Study
Diagnostics·2024· 6 citedOpen Access
Growth differentiation factor-15 is associated with bleeding risk in patients with cancer: results from a prospective cohort
Hämostaseologie·2024· 1 cited
Supplementary Figure 2 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Table 2 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Legend of Supplementary Figures from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Table 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 4 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Legend of Supplementary Figures from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Data from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 3 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Data from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Table 1 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
Supplementary Figure 2 from Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Philipp Saiko(17), Walter Jäger(12), Monika Fritzer‐Szekeres(11), Walter Jaeger(9), Zsuzsanna Bagó-Horváth(9), Michael Grusch(9), Georg Krupitza(9), Thomas Erker(6), Sibylle Madlener(6), Theresia Thalhammer(6), Benedikt Giessrigl(6), Marek Murias(5), Norbert Handler(5), Alexandra Maier‐Salamon(5), Richard Pacher(4), Caroline Vonach(4), Katharina Viola(4), Christoph Illmer(3), Howard L. Elford(3), Christopher Adlbrecht(3)